Analytics header

Showing posts with label regulated. Show all posts
Showing posts with label regulated. Show all posts

Saturday, November 7, 2026

Democratization & Approachability: The Overlooked Ingredient of Adoption

I recently listened to a podcast about digital technology adoption at a manufacturing facility. It emphasized that technology adoption is helped by making the technology and its adoption approachable. Seems kind of obvious, right? Yet it is never really a focus of how we present the technology or the impending change. We talk about simplifying, explaining, dealing with objections, confronting the skepticism.

The way we go about introducing new technology is typically capability first, or, in a sales process, value first and then capability. Then we wait for the reaction and deal with the outcomes in a reactive way. We simplify once people find something complicated. We explain once they are confused. We handle the objections once they show up. So making digital technology, and especially AI technologies, more approachable is a must.

In all my writing and consulting to this point, approachability has been understood as something that is the result, not the starting point. Now, in the last 2-3 months, I am hearing more and more about it. I think it has to do with the turning of the tide, the fact that executives in the operations space are transitioning from a "wait and see" to a "how do we transform" posture. In the general curiosity about AI specifically, I have observed this need to make the technology, and more critically the transformation it requires, more approachable. They see it as a critical element in getting their operations and organization ready.

Why does approachability matter so much? It is not a new idea. Back in 1989 Fred Davis proposed the Technology Acceptance Model, which says people adopt a technology based on two things: whether it is useful and whether it is easy to use. Usefulness usually carries more weight, which is why we lead with value. But ease of use is what gets people to the value. If it takes too much effort to get started, most never get there.

A good example is Rolls-Royce. When they began experimenting with low-code/no-code on Microsoft Power Apps, the question the team kept asking was "what can we do to make this easy to adopt?" They picked a platform with a familiar look and feel for people who already live in Excel and Word. They started with one small team and one use case, a paper checklist. They supported early adopters as champions and set up an internal app store so people could reuse each other's apps. That two-month proof of concept grew into a community of more than 1,000 citizen developers. Rolls-Royce reported savings of 8 to 10 million pounds through 2022, but their chief digital officer said the bigger win was people feeling they can improve their own day-to-day work.

Notice that none of that was about making the technology less capable. It was about making it easier to start.

I see this especially in regulated industries, and the clearest example I know is “paper-on-glass.” It is an unfortunately loaded term that deserves a post of its own, but here is the short version. People have a deep affinity to paper, and in a regulated operation it is also critical for compliance. Paper is tangible. You can touch it and you can see it. The information written on it feels irrefutable, and it is easy to explain. So when a digital solution looks like paper, it looks like something people already know, and that makes it approachable.


That is why, in many cases, I prefer to create initial solutions that resemble paper to ease adoption of digital solutions. I would not call it paper on glass, that is just the term that resonates in the industry as "easy." It really is a digital solution that purposefully looks like paper and therefore makes the technology more approachable. When people have to be educated, convinced, trained, and talked through objections, then the technology and the impending organizational change needed to adopt it are, by definition, not approachable. Approachability is what closes that distance before the skepticism even starts.

Monday, August 28, 2023

Why Pharma is primed to capitalize on Digital

Digital and GxP compliance - a topic that is in high demand and interest these days. The general skepticism and misunderstanding of people in the quality functions of life sciences manufacturing companies is simply put; the biggest barrier currently in digital adoption. I spend so much time explaining and trying to convey the potential in digital technologies and why they are much more compliant than any paper based documentation method. The paper mindset is a shackle that all pharma and biotech companies have to cut off, now and fast otherwise the implications are dire! And, this is not news; regulators know it, executives know it, operations know it, even the quality leadership in most companies know it. That is why such concepts and guidances as Pharma 4.0, Control Strategy, CSA, Continuous Validation, etc. are being introduced and advocated.  

The industries dependency on paper as a mean of documented evidence for compliance is so engrained that it more than a solution it has become weaved into the culture. The selected attempts to introduce electronic solution for compliance such as eBR, LIMS, QMS, etc have been so painful, expensive and unwieldy that they have left us grasping and finding comfort in the paper based solutions. This has left the industry is in a constant dilemma where we know we need to step into the digital era (the unknown) but feel most comfortable staying in warmth of the paper world (known). While some opt for the compromise of traditional systems as an alternative (another known). 

Pharma and Biotech operations and processes are inherently dependent on data. Unlike other industries where the products are physical and you can see problems and defects, the processes can in most cases only be seen or observed through data. Yet we choose to observe by capturing this data mostly on paper and resist the adoption of digital means - why? Because of preconceived notions of compliance and painful experiences with other systems? This is mind boggling - its like someone with poor vision refusing to get a pair of glasses or contacts with obscure excuses that its "not allowed" (reference to regulatory guidance).

In other manufacturing industries operational excellence is the only way to stay profitable. In the life sciences industries the profit margins allow some leeway in productivity levels but of course have the additional burden of compliance. It means that the opportunity to gain significant productivity improvements are very high, e.g. in the CPG industry productivity increase of less than 1% are welcome. In life science not many will make an effort for such a again. With that in mind think about "the waste of documentation" in most processes - I would venture to say that there is more than 10% productivity increase potential by digitizing all paper records across most operations. 

With this I am making a plea to all my peers in the life sciences manufacturing industries. Adopt a "digital anything" mindset and start the transformation. If you see a piece of paper being used that is your opportunity to start digitizing. It does not have to be an intricate complicated "system" that needs IT and top down approvals. Start small and digitize a paper a day, one paper at a time and you will become digital faster than you have ever imagined. Yes there are regulatory implication but do no use that as an excuse, start the digitization process where the skepticism (or maybe fear) is greatest, e.g. the QA or documentation departments.

If one thing you should take aways from the changing paradigm is that transforming paper to digital is not only a must but also significantly easier than it was in the past. I have said this many times, there are no excuses not to start adopting digital technology, and that means the improvements can be incredibly rewarding.  Eliminate paper there are easier way to capture evidence in the digital world!

Wednesday, December 6, 2017

Smart Manufacturing / Industry 4.0 - 20 years in the making.

Hello everybody, I am back after a bit of an extended hiatus. I am finding my way back to blogging starting with some reflection on the past and view into the future.

In the late 1990s I was part of a international research effort that lay the groundwork for what we know of today as Industry 4.0 or Smart Manufacturing. I specifically was interested in the architecture of what is now known as IIoT. In 2000 I wrote an article in the Journal of Manufacturing Systems about these new concepts and predicted that it would take 15 years to become mainstream. I guess I was young and optimistic, it has already been close to 18 years and although its still not mainstream it has started to move in that direction.

At that time the Internet was at its infancy and we could only dream of what is now possible with today’s technology. it was called many different thing such as multi-agent systems, Holonic Manufacturing Systems, Adaptive Manufacturing, and a few other such concepts. It was also called Intelligent Manufacturing, there was even an international consortium named that (and it still exists www.ims.org!). It is also one of the reasons behind the name of this blog. The joke was that what we did up to then was not intelligent :-) However the underlying assumption was that it will be a paradigm shift, a new way of thinking and a new way of operating that is brought about with technological advances.


Now, in the last many years I have been deeply immersed in the pharmaceutical industry and I have come to understand how immature this industry is from a manufacturing operations and technology perspective. Yes biologic manufacturing is novel, complex and groundbreaking however looking at the operations of a pharma plant with paper based systems, traditional automaton and maybe some MES it is nowhere close to the likes of Automotive, Aerospace and even CPG. Yes, this may be a broad and general statement but there is truth to it! Risk averseness driven by regulatory requirements is clearly one of the reasons and probably also why there is little innovation in the manufacturing operations space here, however that should not be an excuse.

So where am I going with this? I think that the pharma industry is poised to take a generational leap and may be able to skip the current or traditional manufacturing operations paradigms and go directly to Smart Manufacturing - bold! it is going to take more than putting a smart sensor on some equipment or sending some data to the cloud for analytics, but its a start. Most of all it is going to take leadership and a vision. There are a few people out there that I know will be able to do this - you know who you are. I am also ready for the challenge - It is a paradigm shift, we must think differently and operate differently.